fluoxetine has been researched along with Muscular Dystrophy, Animal in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Muscular Dystrophy, Animal: MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waugh, TA | 1 |
| Horstick, E | 1 |
| Hur, J | 1 |
| Jackson, SW | 1 |
| Davidson, AE | 1 |
| Li, X | 1 |
| Dowling, JJ | 1 |
| Hudecki, MS | 1 |
| Pollina, CM | 1 |
| Bhargava, AK | 1 |
| Hudecki, RS | 1 |
2 other studies available for fluoxetine and Muscular Dystrophy, Animal
| Article | Year |
|---|---|
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
Topics: Animals; Base Sequence; Birefringence; Calcium; Disease Models, Animal; Drug Evaluation, Preclinical | 2014 |
Screening of antiserotoninergic drugs with the genetically dystrophic chicken.
Topics: Animals; Aspartate Aminotransferases; Chickens; Creatine Kinase; Drug Evaluation, Preclinical; Ergon | 1980 |